MILAGROS SHEPARD: Open Payments
NPI 1861911364 · MC LEAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 30 payments from 9 companies in 2025. Trend: 2023 $75 · 2024 $391 · 2025 $757
Food & beverage: $657Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $213 |
| Galderma Laboratories, L.P. | 6 | $139 |
| Janssen Biotech, Inc. | 1 | $100 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $76 |
| GENZYME CORPORATION | 3 | $75 |
| ABBVIE INC. | 3 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $48 |
| LEO Pharma Inc. | 1 | $26 |
| Botanix SB Inc | 1 | $16 |
Products named: OPZELURA, AKLIEF, TREMFYA, Cabtreo, DUPIXENT, SKYRIZI, Winlevi, ANZUPGO.
Industry payments across VA — which companies pay providers there.
